Dose-finding Study to Assess the Efficacy, Safety and Tolerability of Tobramycin Inhalation Powder in Patients With Non-Cystic Fibrosis Bronchiectasis and Pulmonary P. Aeruginosa Infection
Clinical trial NCT02712983 · COMPLETED
Trial details
- NCT number
- NCT02712983
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-08
- Primary completion
- 2019-03-20
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.